Cost-effectiveness of bevacizumab-based therapy versus cisplatin plus pemetrexed for the first-line treatment of advanced non-squamous NSCLC in Korea and Taiwan.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples